Detalhe da pesquisa
1.
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
J Neurooncol
; 166(3): 407-415, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153582
2.
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
J Neurooncol
; 168(2): 299-306, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630385
3.
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
J Neurooncol
; 166(3): 417-418, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289531
4.
Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer.
Support Care Cancer
; 24(1): 401-408, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26093975
5.
Guidelines for timely initiation of chemotherapy: a proposed framework for access to medical oncology and haematology cancer clinics and chemotherapy services.
Intern Med J
; 46(8): 964-9, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27553996
6.
Reorganization of mental health services: from institutional to community-based models of care.
East Mediterr Health J
; 21(7): 477-85, 2015 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26442887
7.
Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study.
Intern Med J
; 44(8): 813-7, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25081047
8.
Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours.
Br J Cancer
; 108(10): 1998-2004, 2013 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23652314
9.
Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy.
Support Care Cancer
; 21(6): 1561-8, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23274926
10.
The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer.
Br J Cancer
; 106(1): 61-9, 2012 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22134511
11.
A review of PARP inhibitors: from bench to bedside.
Ann Oncol
; 22(2): 268-79, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20643861
12.
Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering Committee.
Intern Med J
; 41(1b): 75-81, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21272171
13.
An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009.
Intern Med J
; 41(1b): 110-20, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21272175
14.
Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.
J Exp Med
; 172(1): 69-75, 1990 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2193100
15.
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer.
Ann Oncol
; 21(6): 1302-1307, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19917571
16.
The hyaluronate receptor is preferentially expressed on proliferating epithelial cells.
J Cell Biol
; 108(4): 1557-65, 1989 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-2466850
17.
The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan.
J Cell Biol
; 116(4): 1055-62, 1992 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-1370836
18.
The hyaluronate receptor is associated with actin filaments.
J Cell Biol
; 105(3): 1395-404, 1987 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-2443509
19.
Binding of hyaluronate to the surface of cultured cells.
J Cell Biol
; 82(2): 475-84, 1979 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-479311
20.
The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins.
J Cell Biol
; 111(6 Pt 1): 2765-74, 1990 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-1703543